147 related articles for article (PubMed ID: 35638866)
1. Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvement.
Robinson P; Bacon CM; Lim SJ; Shaaban AM; Brierley D; Lewis I; Harrison DJ; Kendall TJ; Robinson M
J Pathol Clin Res; 2022 Sep; 8(5):411-421. PubMed ID: 35638866
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
Kendall TJ; Robinson M; Brierley DJ; Lim SJ; O'Connor DJ; Shaaban AM; Lewis I; Chan AW; Harrison DJ;
Lancet Oncol; 2021 Oct; 22(10):e435-e445. PubMed ID: 34592193
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
[TBL] [Abstract][Full Text] [Related]
7. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.
Tan ZW; Tan AC; Li T; Harris I; Naylor JM; Siebelt M; van Tiel J; Pinheiro M; Harris L; Chamberlain K; Adie S
BMJ Open; 2020 Aug; 10(8):e038283. PubMed ID: 32847919
[TBL] [Abstract][Full Text] [Related]
8. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
[TBL] [Abstract][Full Text] [Related]
9. SPIRIT 2013 statement: defining standard protocol items for clinical trials.
Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krleža-Jerić K; Hróbjartsson A; Mann H; Dickersin K; Berlin JA; Doré CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
Ann Intern Med; 2013 Feb; 158(3):200-7. PubMed ID: 23295957
[TBL] [Abstract][Full Text] [Related]
10. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krle A-Jerić K; Hrobjartsson A; Mann H; Dickersin K; Berlin JA; Dore CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
Rev Panam Salud Publica; 2015 Dec; 38(6):506-14. PubMed ID: 27440100
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta-aggregation.
Lim SJ; Gurusamy K; O'Connor D; Shaaban AM; Brierley D; Lewis I; Harrison D; Kendall TJ; Robinson M
J Pathol Clin Res; 2021 May; 7(3):191-202. PubMed ID: 33635586
[TBL] [Abstract][Full Text] [Related]
12. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
Calvert M; King M; Mercieca-Bebber R; Aiyegbusi O; Kyte D; Slade A; Chan AW; Basch E; Bell J; Bennett A; Bhatnagar V; Blazeby J; Bottomley A; Brown J; Brundage M; Campbell L; Cappelleri JC; Draper H; Dueck AC; Ells C; Frank L; Golub RM; Griebsch I; Haywood K; Hunn A; King-Kallimanis B; Martin L; Mitchell S; Morel T; Nelson L; Norquist J; O'Connor D; Palmer M; Patrick D; Price G; Regnault A; Retzer A; Revicki D; Scott J; Stephens R; Turner G; Valakas A; Velikova G; von Hildebrand M; Walker A; Wenzel L
BMJ Open; 2021 Jun; 11(6):e045105. PubMed ID: 34193486
[TBL] [Abstract][Full Text] [Related]
13. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.
Rivera SC; Liu X; Chan AW; Denniston AK; Calvert MJ;
BMJ; 2020 Sep; 370():m3210. PubMed ID: 32907797
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.
Gryaznov D; Odutayo A; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Lohner S; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; Cord KM; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Briel M
Trials; 2020 Oct; 21(1):896. PubMed ID: 33115541
[TBL] [Abstract][Full Text] [Related]
17. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. How to use the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) in orthodontic research.
Novaes IC; Clementino LC; Flores-Mir C; Marques LS; Martins-Júnior PA
Dental Press J Orthod; 2022; 27(3):e2220290. PubMed ID: 35792787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
